{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-008676","form_type":"8-K","ticker":"ZSQR","cik":"0001759186","company_name":"Z Squared Inc.","filed_at":"2022-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.008018+00:00","generated_at":"2026-06-20T21:57:11.412057+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Coeptis Therapeutics receives Nasdaq deficiency notice for MVLS below $50M minimum","bullets":["Nasdaq letter dated Dec. 22, 2022; MVLS below $50M for 30 consecutive business days.","Company has 180 calendar days, until June 20, 2023, to regain compliance.","If MVLS closes at $50M+ for 10 consecutive business days before deadline, compliance will be achieved.","No immediate effect on listing or trading of COEP common stock or warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-008676","json":"https://secwatch.observer/filing/0001683168-22-008676.json","markdown":"https://secwatch.observer/filing/0001683168-22-008676.md","text":"https://secwatch.observer/filing/0001683168-22-008676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759186/000168316822008676/0001683168-22-008676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759186/000168316822008676/coeptis_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T21:57:11.412057+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19f6950a5faea46bd1216eca3772c88934ba6eef","claim":"Z Squared Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(3)(A), 5810(c)(3)(C)).","evidence_excerpt":"December 22, 2022, the Company received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty consecutive business days, the Market Value of Listed Securities, as defined by Nasdaq (“MVLS”) had been below the $50 million minimum requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(3)(A). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided an initial period of 180 calendar days, or until June 20, 2023, to regain compliance. The letter states that","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759186/000168316822008676/0001683168-22-008676-index.htm","confidence":1.0,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5450(b)(3)(A), 5810(c)(3)(C)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}